Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: Six year follow up in the Copenhagen male study

British Medical Journal

Volumn 312, Issue 7033, 1996, Pages 736-741

  Hein, Hans Ole ^a   Suadicani, Poul ^a   Gyntelberg, Finn ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; CORRELATION FUNCTION; DENMARK; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029927449     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7033.736     Document Type: Article

References (34)

1. Rimm EB, Giovannuci EL, Wilett WC, Colditz GA, Asherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary heart disease in men. Lancet 1991;338:464-8.
2. Castelli WP, Gordon T, Hjortland H, Kagan A, Doyle JT, Hames CG, et al. Alcohol and blood lipids: the cooperative lipoprotein phenotyping study. Lancet 1977;ii:153-5.
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
4. Tunstall-Pedoe H, Kuulasmaa K, Amooyel P, Arveiler D, Rajakangas A-M, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
5. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994;344:1719-23.
6. Gyntelberg F. Physical fitness and coronary heart disease in male residents in Copenhagen aged 40-59. Dan Med Bull 1973;20:1-4.
7. Gyntelberg F. One- and two-years incidence of myocardial infarction in Copenhagen males aged 40-59. Dan Med Bull 1975;22:81-4.
8. Suadicani P, Hein HO and Gyntelberg F. Serum cotinine validated form of smoking does not account for social inequalities in risk of ischaemic heart disease: the Copenhagen Male Study - 4 years' follow-up. Int J Epidem 1994;23:293-300.
9. Svalastoga K. Prestige, class and mobility. Copenhagen: Munksgaard, 1959.
10. Siedel J, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the determination of serum cholesterol. J Clin Chem Biochem 1981;19:838-9.
11. Stahler F, Gruber W, Stinshoff K, Roschlau P. Eine praxis gerechte enzymatische Cholesterin-Bestimmung. Med Lab 1977;30:29-37.
12. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Lipid Res 1970;11:583-95.
13. Lopes-Virella, MF. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
14. Friedewald WT, Levy J, Friedrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-509.
15. Hein HO, Sørensen H, Suadicani P, Gyntelberg F. The Lewis blood group - a new genetic marker of ischaemic heart disease. J Intern Med 1992;232: 481-7.
16. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd ed. Geneva: World Health Organisation, 1982.
17. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964;i:296-300.
18. Medical Research Council's committee on the aetiology of chronic bronchitis-Standardised questionnaires on respiratory symptoms. BMJ 1960;ii:1665.
19. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiological research. Principles and quantitative methods. London: Lifetime Learning Publications, 1982.
20. Norusis M. SPSS/PC + base manual. Chicago, Illinois: SPSS, 1988.
21. Norusis M. SPSS/PC + advanced statistics. Chicago, Illinois: SPSS, 1988.
22. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet 1988;ii:1267-73.
23. Shaper AG. Alcohol and mortality: a review of prospective studies. Br J Addiction 1990;85:837-47.
24. Hein HO, Suadicani P, Sørensen H, Gyntelberg F. Alcohol consumption, Lewis phenotypes, and risk of ischaemic heart disease. Lancet 1993;341: 392-6.
25. Folsom AR. Epidemiology of fibrinogen. Eur Heart J 1955; 16(suppl A):21-3.
26. Heinrich J, Balleisen L, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994;14:54-9.
27. Ridker PM, Vaughan DE, Stampfer J, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994;272:929-33.
28. Hendriks HF, Veenstra J, Velthuis te Wierik EJ, Schaafsma G, Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. BMJ 1994;308:1003-6.
29. Kiechl S, Willeit J, Egger G, Oberhollenzer M, Aichner F. Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects. Results from Bruneck study. Stroke 1994;25:1593-8.
30. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984;76:2-12.
31. Yano K, Rhoads GG, Kagan A. Coffee, alcohol, and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 1977;297: 405-9.
32. Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, et al. Lipoproteins as mediators for the effect of alcohol consumption and cigarette smoking on cardiovascular mortality: results from the lipid research clinics follow-up study. Am J Epidemiol 1987;126:629-37.
33. Suh I, Shatan BJ, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol: the multiple risk factor intervention trial research group. Ann Intern Med 1992;116:881-7.
34. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-34.